Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|September 6, 2014
Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugsPaul Emery, Gaia Gallo, Helen Boyd, et al.
Rheumatology (Oxford, England)|October 22, 2013
Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational dataChristopher Ll Morgan, Paul Emery, Duncan Porter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational CohortSameer Kotak, Jack Mardekian, Nathalie Horowicz-Mehler, et al.
British Journal of Pharmacology|February 6, 2020
Proteolysis-targeting chimeras in drug development: A safety perspectiveKevin Moreau, Muireann Coen, Andrew X Zhang, et al.
The Journal of Biological Chemistry|July 31, 2020
Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding siteLuca Martinelli, Athanassios Adamopoulos, Patrik Johansson, et al.
Assay and Drug Development Technologies|October 12, 2018
A Comparative Study of Fluorescence Assays in Screening for BRD4Pia Hansson, Helen Boyd, Ian L Dale, et al.
Journal of Pharmacological and Toxicological Methods|December 5, 2006
Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockadeMatt Deacon, David Singleton, Nikki Szalkai, et al.
Chemical Science|August 7, 2018
Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligaseEilidh K Leitch, Nagarajan Elumalai, Maria Fridén-Saxin, et al.
FEBS Letters|June 23, 2017
Small-molecule stabilization of the p53 - 14-3-3 protein-protein interactionRichard G Doveston, Ave Kuusk, Sebastian A Andrei, et al.
Communications Biology|September 14, 2024
TUBB4B is essential for the cytoskeletal architecture of cochlear supporting cells and motile cilia developmentUrikhan Sanzhaeva, Helen Boyd-Pratt, Philip T R Bender, et al.
Pageof 3